Director/PDMR Shareholding

By

Regulatory News | 12 Nov, 2021

Updated : 11:10

RNS Number : 2507S
Judges Scientific PLC
12 November 2021
 

Judges Scientific plc

Director/PDMR Shareholding

 

Judges Scientific, a group focused on acquiring and developing companies in the scientific instrument sector, has been made aware of the following purchases of ordinary shares in the Group by Brad Ormsby, Group Finance Director, and Ralph Elman, Non Executive Director, under an automatic dividend reinvestment programme. Full details of which are set out below.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Bradley Ormsby and spouse

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Group Finance Director and spouse

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Judges Scientific plc

b)

 

LEI

 

 

2138004EXWWPTW1JOL31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares in Judges Scientific plc

 

 

GB0032398678

 

b)

 

Nature of the transaction

 

 

Purchase of shares under a dividend reinvestment programme

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

8260p

 

6

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A (single transaction)

e)

 

Date of the transaction

 

 

05/11/21

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market (XLON)

 

 

Director/PDMR Shareholding

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

 

a)

 

Name

 

 

Ralph Elman

 

2

 

Reason for the notification

 

 

a)

 

Position/status

 

 

Non-Executive Director

 

b)

 

Initial notification /Amendment

 

 

Initial notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

 

Name

 

 

Judges Scientific plc

 

b)

 

LEI

 

 

2138004EXWWPTW1JOL31

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares in Judges Scientific plc

 

 

GB0032398678

 

 

b)

 

Nature of the transaction

 

 

Purchase of shares under a dividend reinvestment programme

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

8260p

 

16

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A (single transaction)

 

e)

 

Date of the transaction

 

 

05/11/21

 

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM Market (XLON)

 

 

 

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Broker)

 

Stephane Auton

Iain Sexton

Tel: +44 (0) 20 7408 4090

 

Liberum (Joint Broker)

Bidhi Bhoma

Euan Brown

William Hall

 

Media enquiries:

Alma PR (Financial Public Relations)

 

Tel : +44 (0) 20 3100 2222

 

Sam Modlin

Justine James

Joe Pederzolli 

Tel: +44 (0) 20 3405 0205

judges@almapr.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBBBDBCGBDGBD

Last news